Central venous catheter-related bloodstream infections: Pathogenesis factors, new perspectives in prevention and early diagnosis

Journal of Vascular Access

Volumn 4, Issue 3, 2003, Pages 83-91

  De Cicco, M ^a   Campisi, Costantino ^b   Matovic, M ^a  

^a INRCCS   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; CIPROFLOXACIN; HEPARIN; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTISEPSIS; BACTERIAL COLONIZATION; BIOFILM; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; DRUG EFFICACY; EDITORIAL; HUMAN; PATHOGENESIS;

EID: 0242363123     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980300400302     Document Type: Editorial

References (90)

1. Maki DG. Infections caused by intravascular devices used for infusion therapy: Pathogenesis, prevention and management. In: Bisno AL, Waldvogel FA eds. Infections associated with indwelling medical devices. 2nd ed. Washington DC: American Society for Microbiology 1994: 155-212.
2. Byers & Adal K, Anglim A et al. Case fatality rate of catheter related bloodstream infections: a meta-analysis. Proceeding of the 5th annual meeting of the Society for Hospital Epidemiology of America, 1995 (abstract 43).
3. Heiselman D. Nosocomial bloodstream infections in the critically ill. JAMA 1994; 272: 1819-20.
4. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16: 778-84.
5. Maki DG. Nosocomial bacteraemia - an epidemiologic overview. Am J Med 1981; 70: 719-32.
6. Henderson DK. Bacteremia due to percutaneous intravascular devices. In: Mandell GL, Douglas RG, Bennett JE eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone Press 1995: 2587-99.
7. Danker WM, Spector SA, Fierrer J et al. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis 1987; 9: 743-53.
8. Freeman J, Goldmann DA, Smith NE et al. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990; 323: 301-8.
9. Maki DK, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related blood-stream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997; 127: 257-66.
10. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91 (suppl): S197-205.
11. Raad II, Costerton W, Sabharwal U et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168: 400-7.
12. McGeer A, Righter J. Improving our ability to diagnose infections associated with central venous catheters: Value of Gram's staining and culture of entry site swabs. Can Med Assoc J 1987; 137: 1009-21.
13. Snydman DR, Gorbea HF, Pober BR et al. Predictive value of surveillance skin cultures in total-parenteral-nutrition-related infection. Lancet 1982; 2: 1385-8.
14. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43.
15. John JF Jr. Molecular analysis of nosocomial epidemics. Infect Dis Clin North Am 1989; 3: 683-700.
16. Fuchs PC, Gustafson ME, King JT et al. Assessment of catheter-associated infection risk with the Hickman right atrial catheter. Infect Control 1984; 5: 226-30.
17. Press OW, Ransey PG, Larson EB et al. Hickman catheter infections in patients with malignancies. Medicine 1984; 63: 189-200.
18. Wurzel CL, Halom C, Feldman JG et al. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988; 142: 536-40.
19. Sitges-Serra A, Puig P, Linares J et al. Hub colonization as the initial step in on outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN 1984; 8: 668-72.
20. Cobb DK, High KP, Sawyer RG et al. A controlled trial of scheduled replacement of central venous and pulmonary artery catheters. N Engl J Med 1991; 327: 1062-68.
21. Timsit JF, Sabille V, Farkas JC et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276: 1416-20.
22. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990; 28: 2733-8.
23. Strausbaugh LJ, Sewell DL, Ward TT et al. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 1994; 32: 2299-300.
24. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species; increasing incidence of catheter-related infections. Medicine (Baltimore) 1990; 69: 196-306.
25. Saleh RH, Schorin MA. Bacillus spp. sepsis associated with Hickman catheters in patients with neoplastic diseases. Pediatr Infect Dis J 1987; 6: 851-6.
26. Vaudaux P, Pittet D, Haeberli A et al. Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989; 160: 865-75.
27. Raad II, Luna M, Khalil SM et al. The relationship between the thrombotic and infectious complications of central venous catheters JAMA 1994; 13: 1014-16
28. Bouali A, Robert R, Tronchin G, Senet JM. Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of Candida albicans. J Gen Microbiol 1987; 133: 545-51.
29. Hermann M, Vaudaux PE, Pittet D et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988; 158: 693-701.
30. Lopes JD, Dos Reis M, Brentani RR. Presence of laminin receptors in Staphylococcus aureus. Science 1985; 229: 275-7.
31. Hermann M, Suchard SJ, Boxer LA et al. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991; 59: 279-88.
32. Vaudaux P, Pittet D, Haeberli A et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis 1993; 167: 633-41.
33. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Ann Surg 1985; 202: 653-8.
34. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402.
35. Greenfield JI, Sampath L, Popiskis SJ et al. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine impregnated central venous catheters implanted in swine. Crit Care Med 1995; 23: 894-900.
36. Bach A, Bohrer H, Motsch J et al. Prevention of bacterial colonization of intravenous catheters by anti-septic impregnation of polyurethane polymers. J Antimicrob Chemother 1994; 33: 969-78.
37. Raad I, Darouiche R, Dupuis J et al, and the Texas Medical Center Catheter Study Group. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized double-blind trial. Ann Intern Med 1997; 127: 267-74.
38. Veenstra DL, Saint S, Saha S et al. Efficacy of anti-septic-impregnated central venous catheters in prevention of catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281: 261-7.
39. Ciresi D, Albrecht RM, Volkers PA, Scholten DJ. Failure of an antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996; 62: 641-6.
40. Pemberton LB, Ross V, Cuddy P et al. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Arch Surg 1996; 131: 986-9.
41. Heard SO, Wagle M, Vijayakumar E et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158: 81-7.
42. Logghe C, Van Ossel C, D'Hoore W et al. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of blood-stream infection in leukemia patients: a randomized controlled trial. J Hosp Infect 1997; 37: 147-56.
43. Raad I, Darouiche R, Hachem R et al. The broad spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173: 418-24.
44. Bach A, Schmidt H, Bottiger B et al. Retention of antibacterial activity and bacterial colonization of anti-septic-bonded central venous catheters. J Antimicrob Chemother 1996; 37: 315-22.
45. Tcholakian RK, Raad II. Durability of anti-infective effect of long-term silicone sheath catheters impregnated with antimicrobial agents. Antimicrob Agents Chemother 2001; 45: 1990-3.
46. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-central venous catheter. Anesthesiology 1997; 87: 1242-4.
47. Darouiche RO, Raad II, Heard SO et al, for the Catheter Study Group. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1-8.
48. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47: 589-98.
49. Maki DG, Cobb L, Garman JK et al. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988; 85: 307-14.
50. Bonawitz SC, Hammell JJ, Kirkpatrick JR. Prevention of central venous catheter sepsis: a prospective randomized trial. Am Surg 1991; 57: 518-23.
51. Dahlberg PJ, Agger WA, Singer JR et al. Subclavian hemodialysis catheter infections: a prospective randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol 1995; 15: 506-11.
52. Groeger JS, Lucas AB, Colt D et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993; 218: 206-10.
53. Clementi E, Marie O, Arlet G et al. Usefulness of an attachable silver-impregnated cuff for prevention of catheter-related sepsis (CRS). Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. September 29 to October 2, 1991; Chicago, III, and Washington, DC (abstract 460).
54. Hemmerlein JB, Trerotola SO, Kraus MA et al. In vitro cytotoxicity of silver-impregnated collagen cuffs designed to decrease infection in tunneled catheters. Radiology 1997; 204: 363-7.
55. Raad I, Hachem R, Zermeno A et al. In vitro antimicrobial efficacy of silver iontophoretic catheter. Biomaterials 1996; 17: 1055-9.
56. Raad I, Hachem R, Zermeno A et al. Silver iontophoretic catheter: a prototype of a long term anti-infective vascular access device. J Infect Dis 1996; 173: 495-8.
57. Maki DG, Mermel LA, Kluger D et al. The efficacy of a chlorhexidine-impregnated sponge (biopatch) for the prevention of intravascular catheter-related infection: a prospective, randomized, controlled, multicenter study. Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 17-20, 2000; Toronto, Ontario (abstract 1430).
58. Garland JS, Alex CP, Mueller CD et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infection in neonates. Pediatrics 2001; 107: 1431-6.
59. Kryzwda EA, Andris DA, Edmiston CE Jr, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol 1995; 16: 596-8.
60. Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21: 1286-8.
61. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8: 591-7.
62. Rackoff WR, Weiman M, Jakobowski D et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127: 147-51.
63. Henrickson KJ, Axtell RA, Hoover SM et al. Prevention of central venous catheter-related infections and thrombotic events in immuno-compromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18: 1269-78.
64. Spafford PS, Sinkin RA, Cox C et al. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infections Control Practices Advisory Committee (HICPAC) MMWR Morb Mortal Wkly Rep 1994; 44: 1-13.
65. Sieradzki K, Roberts RB, Serur D et al. Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin. Lancet 1998; 351: 880-1.
66. Hiramatsu K, Aritaka AN, Hanaki H et al. Dissemination in Japanese hospitals of Stophylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
67. Hiramatsu K, Aritaka AN, Hanaki H et al. Interim guidelines for prevention and control of staphylococcal infections associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep 1997; 46: 626-8.
68. Smith TL, Pearson ML, Wilcox KR et al, for the Glycopeptide-Intermediate Staphylococcus aureus Working Group. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
69. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999; 340: 517-23.
70. Raad I, Buzaid A, Ryne J et al. Minocycline and ethylenediaminetetracetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25: 149-51.
71. Bleyer A, Mason L, Raad I, Sherertz R. A randomized, double-blind trial comparing minocycline/EDTA vs heparin as flush solutions for hemodialysis catheters. Program and abstracts of 4th Decennial Conference Program Committee. March 5-9, 2000; Atlanta, Ga. (abstract P-S1-31).
72. Segura M, Alla C, Valverde J et al. Assessment of a new hub design and the semiquantitative catheter culture method using an in vivo experimental model of catheter sepsis. J Clin Microbiol 1990; 28: 2551-4.
73. Segura M, Alvarez-Lerma F, Tellabo JM et al. Advances in surgical technique: a clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 1996; 223: 363-9.
74. Luna L, Masdeu G, Perez M et al. Clinical trial evaluating a new hub device designed to prevent catheter-related sepsis. Eur J Clin Microbiol Infect Dis 2000; 19: 655-62.
75. Siegman-Igra Y, Anglim AM, Shapiro D et al. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997; 35: 928-36.
76. Leisure MK, Moore DM, Schwartzmam JD. Changing the needle when inoculating blood cultures: a no benefit and high risk procedure. JAMA 1990; 264: 2111-12
77. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24: 262-77.
78. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infections. N Engl J Med 1977; 296: 1305-9.
79. Sherertz RJ, Raad II, Belani A et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28: 76-82.
80. Brun-Buisson C, Abrouk F, Legrand P et al. Diagnosis of central venous catheter-related sepsis: critical level of quantitative tip cultures. Arch Intern Med 1987; 147: 873-7.
81. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis 1987; 141: 781-6.
82. Sherertz RJ, Heard SO, Raad II. Diagnosis of triplelumen catheter infection: comparison of roll plate, sonication and flushing methodologies. J Clin Microbiol 1997; 35: 641-6.
83. Raad II, Sabbagh MF, Rand KH, Sherertz RJ. Quantitative tip culture methods and the diagnosis of central venous catheter-related infections. Diagn Microbiol Infect Dis 1992; 15: 13-20.
84. Widmer AF, Nettleman M, Flint K, Wenzel RP. The clinical impact of culturing central venous catheters: a prospective study. Arch Intern Med 1992; 152: 1299-302.
85. Capdevila JA, Planes AM, Palomar M et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis 1992; 11: 403-7.
86. Flynn P, Sheneb J, Strokes D, Barret F. "In situ: management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis 1987; 6: 729-34.
87. Blot F, Schmidt E, Nitenberg G et al. Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36: 105-9.
88. Blot F, Nitenberg G, Chachaty E et al. Diagnosis of catheter-related bacteremia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354: 1071-7.
89. Kite P, Dobbins BM, Wilcox MH et al. Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter-related sepsis. J Clin Pathol 1997; 50: 278-82.
90. Kite P, Dobbins BM, Wilcox MH, McMahon MJ. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet 1999; 354: 1504-7.